PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
32.91%
Net income growth under 50% of AVGO's 100.00%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
4.03%
D&A growth well above AVGO's 3.45%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
85.28%
Some yoy growth while AVGO is negative at -100.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
1.53%
SBC growth while AVGO is negative at -4.85%. John Neff would see competitor possibly controlling share issuance more tightly.
37.10%
Less working capital growth vs. AVGO's 100.00%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-35.96%
Both yoy AR lines negative, with AVGO at -70.18%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-10.31%
Negative yoy inventory while AVGO is 737.50%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-39.05%
Both negative yoy AP, with AVGO at -122.79%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
112.91%
Growth well above AVGO's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-37100.00%
Negative yoy while AVGO is 2198.75%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
56.83%
Operating cash flow growth above 1.5x AVGO's 12.92%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
8.63%
Lower CapEx growth vs. AVGO's 29.07%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-40.75%
Negative yoy purchasing while AVGO stands at 58.90%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-38.37%
We reduce yoy sales while AVGO is 300.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
74.14%
We have some outflow growth while AVGO is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-92.71%
Both yoy lines negative, with AVGO at -104.07%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment similar to AVGO's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
No Data
No Data available this quarter, please select a different quarter.
30.15%
Repurchase growth above 1.5x AVGO's 10.81%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.